Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drugs
Biotech
Chai brews up $400M series C to fuel AI used by Lilly and Pfizer
Chai Discovery continued its whirlwind emergence, closing its third financing round in less than a year to bring its total haul above $600 million.
Nick Paul Taylor
Jul 14, 2026 10:03am
Fierce Pharma
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am
Leads Biolabs hits Hong Kong stock exchange in $189M IPO
Jul 25, 2025 10:59am
Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova
Jul 15, 2025 10:16am
Biocon accused of IP theft to create cancer biotech Bicara
Oct 24, 2024 11:04am
AstraZeneca preps new COVID push after antibody's ph. 3 success
May 16, 2024 7:15am